RCKT: Rocket Pharmaceuticals Inc
今日RCKT汇率已更改-5.98%。当日,交易品种以低点2.17和高点2.39进行交易。
关注Rocket Pharmaceuticals Inc动态。实时报价将帮助您快速应对市场变化。通过在不同的时间周期之间切换,您可以按分钟、小时、天、周和月监控汇率趋势和动态。使用这些信息来预测市场变化并做出明智的交易决策。
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
RCKT新闻
- Goldman Sachs Upgrades Rocket Pharmaceuticals to Neutral, Raises Price Target to $4
- Leerink Partners Maintains Market Perform on Rocket Pharmaceuticals, Lowers Price Target to $4
- Rocket Pharmaceuticals公布Danon病投资者网络研讨会关键数据及研发里程碑,展示其在修订方案下接受治疗的受试者中开展的关键性II期研究
- Rocket Pharmaceuticals Reports Key Data, Development Milestones Demonstrated During Danon Disease Investor Webinar For Its Pivotal Phase 2 Study In Participants Treated Under Modified Protocol
- Wedbush Reiterates Outperform on Rocket Pharmaceuticals, Maintains $15 Price Target
- Rocket Pharmaceuticals, Inc. (RCKT) Discusses Danon Disease Program Update With Focus on RP-A501 Pivotal Trial and Preliminary Clinical Data Transcript
- Rocket Pharmaceuticals, Inc. (RCKT) Discusses Danon Disease Program Update With Focus on RP-A501 Pivotal Trial and Preliminary Clinical Data - Slideshow (NASDAQ:RCKT) 2026-10-07
- Rocket Pharmaceuticals宣布与Hercules Capital达成最高1.5亿美元信贷额度,交割时已收到3500万美元;预计现金可支撑至2028年第三季度
- Rocket Pharmaceuticals Announces Up To $150M Credit Facility With Hercules Capital, $35M Received At Closing; Expects Cash Runway Into Q3 2028
- This JB Hunt Transport Analyst Turns Bullish; Here Are Top 4 Upgrades For Thursday
- 亨特运输分析师转为看涨;以下是周四的四大升级。
- RCKT Aligns With FDA on Completing Phase II Study in Danon Disease
- Allogene Therapeutics (ALLO) Down 11.1% Since Last Earnings Report: Can It Rebound?
- Why Is AtaiBeckley Inc (ATAI) Up 0.8% Since Last Earnings Report?
- Rocket Pharmaceuticals (RCKT) Up 6% Since Last Earnings Report: Can It Continue?
- Monopar: Licensing Agreement, Rolling NDA Submission Serve As Catalysts For ‘Strong Buy’
常见问题解答
RCKT股票今天的价格是多少?
Rocket Pharmaceuticals Inc股票今天的定价为2.20。它在2.17 - 2.39范围内交易,昨天的收盘价为2.34,交易量达到3063。RCKT的实时价格图表显示了这些更新。
Rocket Pharmaceuticals Inc股票是否支付股息?
Rocket Pharmaceuticals Inc目前的价值为2.20。股息政策取决于公司,而投资者也会关注-40.86%和USD。实时查看图表以跟踪RCKT走势。
如何购买RCKT股票?
您可以以2.20的当前价格购买Rocket Pharmaceuticals Inc股票。订单通常设置在2.20或2.50附近,而3063和-5.98%显示市场活动。立即关注RCKT的实时图表更新。
如何投资RCKT股票?
投资Rocket Pharmaceuticals Inc需要考虑年度范围2.17 - 5.45和当前价格2.20。许多人在以2.20或2.50下订单之前,会比较-16.03%和。实时查看RCKT价格图表,了解每日变化。
Rocket Pharmaceuticals Inc股票的最高价格是多少?
在过去一年中,Rocket Pharmaceuticals Inc的最高价格是5.45。在2.17 - 5.45内,该股波动显著,与相比有助于发现阻力位。使用实时图表跟踪Rocket Pharmaceuticals Inc的绩效。
Rocket Pharmaceuticals Inc股票的最低价格是多少?
Rocket Pharmaceuticals Inc(RCKT)的最低价格为2.17。将其与当前的2.20和2.17 - 5.45进行比较,可以发现潜在的长期切入点。观看RCKT在图表上的实时走势以获取更多详细信息。
RCKT股票是什么时候拆分的?
Rocket Pharmaceuticals Inc历史上曾经历过股票拆分。这些变化在公司行动后的、2.34和-40.86%中可见。
- 前一天收盘价
- 2.34
- 开盘价
- 2.34
- 卖价
- 2.20
- 买价
- 2.50
- 最低价
- 2.17
- 最高价
- 2.39
- 交易量
- 3.063 K
- 日变化
- -5.98%
- 月变化
- -16.03%
- 6个月变化
- -36.42%
- 年变化
- -40.86%
- 实际值
- -3.060 M
- 预测值
- -4.804 M
- 前值
- -8.557 M
- 实际值
- 0.987 M
- 预测值
- -0.153 M
- 前值
- 1.862 M
- 实际值
- 预测值
- 前值
- 5.420%